SubsAtlas
High-risk education Compare

LSD vs Psilocybin Mushrooms

Educational comparison of psychedelic profiles, reported effects, evidence context and risk awareness.

Educational context

This comparison covers reported effects, risk profiles, evidence quality and interaction concerns. It is not a recommendation, use guide or ranking.

LSD compound visual — founder-provided scientific education visual
High-risk education
Founder-provided scientific education visual. Educational context only. Not a use guide. Source and license pending review.
High-risk educationElevated riskModerate evidenceHigh-risk education

LSD

Legal status varies by region. This profile is for educational context only.

Psilocybin mushroom specimen — founder-provided scientific education visual
Fungi
Founder-provided scientific education visual. Educational context only. Not identification guidance. Source and license pending review.
FungiHigh riskModerate evidenceHigh-risk education

Psilocybin Mushrooms

Controlled in most jurisdictions. Legal status varies by country, and in some places by specific species or context. This profile is for educational context only.

Images are educational visuals. Plant and fungi visuals are not identification guidance.

Education profile

High-risk comparison

This comparison includes high-risk profiles. Use this information for risk awareness and educational context only.

SubsAtlas does not rank substances as better, safer or more suitable.

Compared profiles

Educational profiles for LSD and Psilocybin Mushrooms.

LSD compound visual — founder-provided scientific education visual
High-risk education
Founder-provided scientific education visual. Educational context only. Not a use guide. Source and license pending review.
High-risk educationElevated riskModerate evidenceHigh-risk education

LSD

High-risk education profile focused on perception changes, psychological distress and legal context.

Key caution

Psychological distress risk

Full profile
Psilocybin mushroom specimen — founder-provided scientific education visual
Fungi
Founder-provided scientific education visual. Educational context only. Not identification guidance. Source and license pending review.
FungiHigh riskModerate evidenceHigh-risk education

Psilocybin Mushrooms

Psilocybin-containing fungi with intense psychological effects, high anxiety potential and serious legal restrictions in most jurisdictions.

Key caution

Psychological distress, panic reactions and difficult psychological experiences are documented risks — particularly at higher exposures

Full profile

Comparison matrix

Side-by-side educational context. Not a recommendation or ranking.

Dimension
LSD compound visual — founder-provided scientific education visual
High-risk education

LSD

High-risk education
Psilocybin mushroom specimen — founder-provided scientific education visual
Fungi

Psilocybin Mushrooms

High-risk education
Category
High-risk education
Fungi
Reported profile
Altered perception, Emotional shifts, Anxiety potential, Sleep disruption
Altered visual and auditory perception, Emotional shifts — both positive and distressing, Altered sense of time, Nausea at onset, Psychological distress at high exposures
Risk level
Elevated risk
High risk
Evidence quality
Moderate evidence
Moderate evidence
Main cautions
Psychological distress risk; Anxiety and panic concerns; Impairment risk; Legal restrictions
Psychological distress, panic reactions and difficult psychological experiences are documented risks — particularly at higher exposures; Adverse mental health outcomes are elevated in those with personal or family history of psychosis or mood disorders; Psilocybin can trigger or worsen underlying mental health conditions — individual vulnerability is not always apparent in advance; Controlled substance in most jurisdictions — serious legal consequences in most regions; Wild foraging carries risk of poisoning from misidentification of toxic species — do not forage without expert botanical identification; Do not drive or operate machinery — significant impairment of perception, coordination and judgment
Interaction concerns
Combining with other psychoactive or serotonergic substances may increase risk and is not recommended.
Psilocybin combined with MAOIs may intensify effects significantly and carries serotonin syndrome risk. Combining with lithium has been associated with adverse outcomes in documented cases. Combination with other psychoactives increases unpredictability and psychological distress risk.
Duration range
Varies by context
General educational range only
Community Signal
Community Signal requires moderated structured reports.
Preview signal — not from live moderated reports. Psychological effects can be intense, distressing and highly unpredictable.
Legal context
Legal context varies
Restricted / controlled

AI Context

Educational comparison summary from curated archive data. Not a ranking or recommendation.

AI ContextPreviewComparison

LSD and Psilocybin Mushrooms: comparison overview

This is an educational comparison summary of LSD and Psilocybin Mushrooms, not a ranking or recommendation. LSD has a elevated risk profile with moderate evidence quality. Psilocybin Mushrooms has a high risk profile with moderate evidence quality. SubsAtlas does not rank substances as better, more suitable or preferable.

  • LSD: Elevated risk, Moderate evidence.
  • Psilocybin Mushrooms: High risk, Moderate evidence.
  • LSD category: High-risk education.
  • Psilocybin Mushrooms category: Fungi.
  • Legal context — LSD: varies by region.
  • Legal context — Psilocybin Mushrooms: controlled.

This comparison includes high-risk education profiles. AI Context does not provide use or combination guidance.

Related

LSD profilePsilocybin Mushrooms profileCompare all profiles

Limitations

  • This is an educational comparison, not a ranking or recommendation.
  • Neither substance is described as better, safer or more suitable.
  • Based on curated SubsAtlas archive data only.
  • Not medical advice. Not legal advice. Not a use guide.
  • Individual responses vary. Source review is ongoing.
  • Do not rely on this for personal decisions.

AI Context summarizes curated SubsAtlas archive data only. Not medical advice. Not legal advice. Not a use guide. No external AI calls are made.

Key differences

Factual educational distinctions between the two profiles.

LSD is a synthetic compound; psilocybin mushrooms are natural fungi containing psilocybin and psilocin.

LSD is generally reported to have a longer effect duration than psilocybin mushrooms.

Both act primarily at 5-HT2A serotonin receptors, producing psychedelic effects including perceptual changes and altered cognition.

Psilocybin has received FDA Breakthrough Therapy designation for research into depression treatment; LSD has a history of earlier research interest that was largely paused due to regulatory changes.

Illicit LSD carries product quality risk, including misrepresentation with other substances. Psilocybin mushroom identification carries its own risk in foraging contexts.

Both are scheduled substances in most jurisdictions, though legal status and research access is evolving in some regions.

Risk context

Both substances can produce intense and disorienting experiences that may be distressing, particularly in unfamiliar or unsupported settings. Psychological risk is significant, especially for individuals with personal or family history of psychosis or schizophrenia-spectrum conditions. Both are contraindicated in conjunction with lithium due to serious interaction risk. Neither carries high acute physical toxicity in isolation, but psychological risk is not trivial. Individual response varies significantly.

Evidence context

Psilocybin has an active and growing clinical research base in recent years, particularly for depression, anxiety and addiction contexts. LSD has a historic research base and newer study activity, though regulatory barriers remain. Community-reported data for both is substantial but should be interpreted alongside evidence quality ratings. Research settings differ significantly from uncontrolled exposure contexts.

Interaction concerns

Shown for risk awareness only. SubsAtlas does not describe any combination as safe.

Both substances carry serious interaction risks with lithium, which has been associated with seizure risk in case reports. Combination with serotonergic substances carries serotonin syndrome risk. MAOIs significantly alter the effects and risk profile of both substances. This page does not describe any combination as safe or provide combination guidance.

Legal context

Legal status varies by country, state and local regulation. This is educational context only — not legal advice.

LSD

Legal status varies by region. This profile is for educational context only.

Psilocybin Mushrooms

Psilocybin mushrooms are controlled substances in most countries and jurisdictions, with regulated exceptions emerging in some regions for supervised clinical or therapeutic contexts. Possession and use is prohibited in most regions. This profile is for educational context only.

Legal status varies by jurisdiction and changes over time. Verify current local law through official sources. How legal context works

Related safety topics

Educational context pages relevant to this comparison.

Interaction awareness

Serotonergic substances

Some substances affect serotonin systems. Combining serotonergic substances may increase serious risk.

Elevated riskRead
Product quality

Unknown product quality

Unknown contents, contamination, mislabeling and variable potency can increase risk.

High riskRead

Related profiles

Educational profiles with related risk or effect context.

Educational visual for Amanita Muscaria profile — Amanita muscaria fungus
Fungi
Educational visual — visual source pending review. Not identification guidance.
138 reports
High-risk education
FungiHigh risk

Amanita Muscaria

High-caution fungus with a distinct pharmacological profile from psilocybin mushrooms. Misidentification and ibotenic acid toxicity are serious risks.

Not the same as psilocybin mushrooms — different compounds, different pharmacology, different risk profile

Legal: Legal context varies

Limited evidence
MDMA compound visual — founder-provided scientific education visual
High-risk education
Founder-provided scientific education visual. Educational context only. Not a use guide. Source and license pending review.
0 reports
High-risk education
High-risk educationElevated risk

MDMA

High-risk education profile focused on overheating, cardiovascular, mood and interaction concerns.

Adulteration risk — substances sold as MDMA frequently contain other compounds including fentanyl

Legal: Restricted / controlled

Moderate evidence

Full educational profiles

Explore each substance profile for complete effects, risk and evidence context.

LSD

High-risk education profile focused on perception changes, psychological distress and legal context.

Psilocybin Mushrooms

Psilocybin-containing fungi with intense psychological effects, high anxiety potential and serious legal restrictions in most jurisdictions.

← Compare another profileExplore the AtlasHow SubsAtlas handles evidence and risk

Educational information only. Not medical advice. Effects, risks and responses vary by individual. SubsAtlas does not provide dosing, sourcing, preparation or optimization guidance.